4//SEC Filing
AzurRx BioPharma, Inc. 4
Accession 0001415889-17-000210
$GRDXCIK 0001604191operating
Filed
Feb 6, 7:00 PM ET
Accepted
Feb 7, 4:36 PM ET
Size
5.1 KB
Accession
0001415889-17-000210
Insider Transaction Report
Form 4
Spoor Johan M.
DirectorPresident and CEO
Transactions
- Award
Options
2017-02-03+100,000→ 100,000 totalExercise: $4.48From: 2017-02-03Exp: 2027-02-03→ Common Stock (100,000 underlying)
Documents
Issuer
AzurRx BioPharma, Inc.
CIK 0001604191
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001604191
Filing Metadata
- Form type
- 4
- Filed
- Feb 6, 7:00 PM ET
- Accepted
- Feb 7, 4:36 PM ET
- Size
- 5.1 KB